Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00453.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Sachin Aryal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, College of Medicine and Life Sciences, University of Toled…. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Metabolic Syndrome, Lipolysis, Histones. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), American Heart Association (AHA), NHLBI NIH HHS.
Abstract (Originalsprache)
This is the first study to demonstrate that exogenous β-hydroxybutyrate supplementation attenuates metabolic syndrome (MetS) and identifies histone β-hydroxybutyrylation-mediated chromatin remodeling as one of the mechanisms to upregulate the transcription of the lipid catabolic genes, Hmgcs2, Cyp2d4, Cyp2e1, and Acaa1b. Our work constitutes a strong foundation for the use of 1,3-butanediol as an alternative epigenetic therapeutic for individuals who are physically unable to achieve the MetS lowering benefits of lifestyle modifications such as exercise and intermittent fasting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, United States.
- College of Pharmacy, North Sichuan Medical College, Nanchong, China.
ORCID-Profile: Sachin Aryal, Ishan Manandhar, Beng San Yeoh, Bina Joe
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- American Heart Association (AHA)
- NHLBI NIH HHS
- American Liver Foundation (ALF)
Zitieren
APA
Aryal, S., Mell, B., Manandhar, I., Yeoh, B. S., Mei, X., Akinola, O. M., Ahlidja, W., & Joe, B. (2025). Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00453.2025
Vancouver
Aryal S, Mell B, Manandhar I, Yeoh BS, Mei X, Akinola OM, et al. Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00453.2025
BibTeX
@article{Aryal2025,
author = {Aryal, Sachin and Mell, Blair and Manandhar, Ishan and Yeoh, Beng San and Mei, Xue and Akinola, Oluwatosin Mautin and Ahlidja, Wisdom and Joe, Bina},
title = {Ketone body β-hydroxybutyrate-mediated histone β-hydroxybutyrylation upregulates lipolysis and attenuates metabolic syndrome},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00453.2025}
}
EUVIMED